The role of apoptosis in cancer development and treatment response (original) (raw)

• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS PubMed Google Scholar
• Sarasin, A. An overview of the mechanisms of mutagenesis and carcinogenesis. Mutat. Res. 544, 99–106 (2003).
  Article CAS PubMed Google Scholar
• Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 (1997).
  Article CAS PubMed Google Scholar
• Vousden, K. H. & Lu, X. Live or let die: the cell's response to p53. Nature Rev. Cancer 2, 594–604 (2002).
  Article CAS Google Scholar
• Attardi, L. D. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models. Mutat. Res. 569, 145–157 (2005).
  Article CAS PubMed Google Scholar
• Schmitt, C. A. et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335–346 (2002).
  Article CAS PubMed Google Scholar
• Hall, E. J. Radiobiology for the Radiologist (J. B. Lippincott Company, Philadelphia, 2000).
  Google Scholar
• Wouters, B. G., Denko, N. C., Giaccia, A. J. & Brown, J. M. A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy. Oncogene 18, 6540–6545 (1999).
  Article CAS PubMed Google Scholar
• Koike, M. et al. Dependence of chemotherapy response on p53 mutation status in a panel of human cancer lines maintained in nude mice. Cancer Sci. 95, 541–546 (2004).
  Article CAS PubMed Google Scholar
• Fichtner, I. et al. Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas. Eur. J. Cancer 40, 298–307 (2004).
  Article CAS PubMed Google Scholar
• Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A. & Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847–849 (1993).
  Article CAS PubMed Google Scholar
• Clarke, A. R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849–852 (1993).
  Article CAS PubMed Google Scholar
• Lowe, S. W., Ruley, H. E., Jacks, T. & Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957–967 (1993).
  Article CAS PubMed Google Scholar
• Lowe, S. W. et al. p53 status and the efficacy of cancer therapy in vivo. Science 266, 807–810 (1994).
  Article CAS PubMed Google Scholar
• Weinstein, J. N. et al. An information-intensive approach to the molecular pharmacology of cancer. Science 275, 343–349 (1997).
  Article CAS PubMed Google Scholar
• Amundson, S. A. et al. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60, 6101–6110 (2000).
  CAS PubMed Google Scholar
• Abend, M. Reasons to reconsider the significance of apoptosis for cancer therapy. Int. J. Radiat. Biol. 79, 927–941 (2003).
  Article CAS PubMed Google Scholar
• Okada, H. & Mak, T. W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nature Rev. Cancer 4, 592–603 (2004).
  Article CAS Google Scholar
• Zong, W. X., Ditsworth, D., Bauer, D. E., Wang, Z. Q. & Thompson, C. B. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 18, 1272–1282 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W. & Vogelstein, B. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401, 616–620 (1999).
  Article CAS PubMed Google Scholar
• Chu, K., Teele, N., Dewey, M. W., Albright, N. & Dewey, W. C. Computerized video time lapse study of cell cycle delay and arrest, mitotic catastrophe, apoptosis and clonogenic survival in irradiated 14-3-3σ and CDKN1A (p21) knockout cell lines. Radiat. Res. 162, 270–286 (2004).
  Article CAS PubMed Google Scholar
• Forrester, H. B., Albright, N., Ling, C. C. & Dewey, W. C. Computerized video time-lapse analysis of apoptosis of REC:Myc cells X-irradiated in different phases of the cell cycle. Radiat. Res. 154, 625–639 (2000).
  Article CAS PubMed Google Scholar
• Masters, J. R. & Koberle, B. Curing metastatic cancer: lessons from testicular germ-cell tumours. Nature Rev. Cancer 3, 517–525 (2003).
  Article CAS Google Scholar
• Taniguchi, T. et al. Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors. Nature Med. 9, 568–574 (2003).
  Article CAS PubMed Google Scholar
• Gurubhagavatula, S. et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J. Clin. Oncol. 22, 2594–2601 (2004).
  Article CAS PubMed Google Scholar
• Endlich, B., Radford, I. R., Forrester, H. B. & Dewey, W. C. Computerized video time-lapse microscopy studies of ionizing radiation-induced rapid-interphase and mitosis-related apoptosis in lymphoid cells. Radiat. Res. 153, 36–48 (2000).
  Article CAS PubMed Google Scholar
• Puck, T. T. & Markus, P. I. Action of x-rays on mammalian cells. J. Exper. Med. 103, 653–666 (1956).
  Article CAS Google Scholar
• Reinhold, H. S. & De Bree, C. Tumour cure rate and cell survival of a transplantable rat rhabdomyosarcoma following x-irradiation. Eur. J. Cancer 4, 367–374 (1968).
  Article CAS PubMed Google Scholar
• Durand, R. E. Cure, regression and cell survival: a comparison of common radiobiological endpoints using an in vitro tumour model. Br. J. Radiol. 48, 556–571 (1975).
  Article CAS PubMed Google Scholar
• Teicher, B. A. in Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development (ed. Prendergast, G. C.) 7–40 (John Wiley and Sons, Hoboken, New Jersey, 2004).
  Book Google Scholar
• Waldman, T. et al. Cell-cycle arrest versus cell death in cancer therapy. Nature Med. 3, 1034–1036 (1997).
  Article CAS PubMed Google Scholar
• Wouters, B. G., Giaccia, A. J., Denko, N. C. & Brown, J. M. Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis- independent mechanism. Cancer Res. 57, 4703–4706 (1997).
  CAS PubMed Google Scholar
• Bunz, F. et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104, 263–269 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Brown, J. M. NCI's anticancer drug screening program may not be selecting for clinically active compounds. Oncol. Res. 9, 213–215 (1997).
  CAS PubMed Google Scholar
• Ruth, A. C. & Roninson, I. B. Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation. Cancer Res. 60, 2576–2578 (2000).
  CAS PubMed Google Scholar
• Brown, J. M. & Giaccia, A. J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408–1416 (1998).
  CAS PubMed Google Scholar
• Schmitt, C. A., Rosenthal, C. T. & Lowe, S. W. Genetic analysis of chemoresistance in primary murine lymphomas. Nature Med. 6, 1029–1035 (2000).
  Article CAS PubMed Google Scholar
• Withers, H. R., Mason, K. A. & Thames, H. D. Jr. Late radiation response of kidney assayed by tubule-cell survival. Br. J. Radiol. 59, 587–595 (1986).
  Article CAS PubMed Google Scholar
• Tucker, S. L. et al. Direct analyses of in vivo colony survival after single and fractionated doses of radiation. Int. J. Radiat. Biol. 59, 777–795 (1991).
  Article CAS PubMed Google Scholar
• Hendry, J. H., Cai, W. B., Roberts, S. A. & Potten, C. S. p53 deficiency sensitizes clonogenic cells to irradiation in the large but not the small intestine. Radiat. Res. 148, 254–259 (1997).
  Article CAS PubMed Google Scholar
• Potten, C. S. & Grant, H. K. The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. Br. J. Cancer 78, 993–1003 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Komarova, E. A. et al. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 16, 1391–1400 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Song, S. & Lambert, P. F. Different responses of epidermal and hair follicular cells to radiation correlate with distinct patterns of p53 and p21 induction. Am. J. Pathol. 155, 1121–1127 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Gudkov, A. V. & Komarova, E. A. The role of p53 in determining sensitivity to radiotherapy. Nature Rev. Cancer 3, 117–129 (2003).
  Article CAS Google Scholar
• Held, K. D. Radiation-induced apoptosis and its relationship to loss of clonogenic survival. Apoptosis 2, 265–282 (1997).
  Article CAS PubMed Google Scholar
• Aldridge, D. R., Arends, M. J. & Radford, I. R. Increasing the susceptibility of the rat 208F fibroblast cell line to radiation-induced apoptosis does not alter its clonogenic survival dose–response. Br. J. Cancer 71, 571–577 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Han, J. W., Dionne, C. A., Kedersha, N. L. & Goldmacher, V. S. p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc. Cancer Res. 57, 176–182 (1997).
  CAS PubMed Google Scholar
• Lock, R. B. & Stribinskiene, L. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res. 56, 4006–4012 (1996).
  CAS PubMed Google Scholar
• Yin, D. X. & Schimke, R. T. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res. 55, 4922–4928 (1995).
  CAS PubMed Google Scholar
• Tannock, I. F. & Lee, C. Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br. J. Cancer 84, 100–105 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Ekert, P. G. et al. Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J. Cell Biol. 165, 835–842 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Westphal, C. H. et al. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nature Genet. 16, 397–401 (1997).
  Article CAS PubMed Google Scholar
• Merritt, A. J., Allen, T. D., Potten, C. S. & Hickman, J. A. Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after γ-irradiation. Oncogene 14, 2759–2766 (1997).
  Article CAS PubMed Google Scholar
• Kemp, C. J., Sun, S. & Gurley, K. E. p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent. Cancer Res. 61, 327–332 (2001).
  CAS PubMed Google Scholar
• Ling, V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40 (Suppl.), 3–8 (1997).
  Article Google Scholar
• Tannock, I. F. Tumor physiology and drug resistance. Cancer Metastasis Rev. 20, 123–132 (2001).
  Article CAS PubMed Google Scholar
• Townsend, D. M. & Tew, K. D. The role of glutathione-_S_-transferase in anti-cancer drug resistance. Oncogene 22, 7369–7375 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Brown, J. M. & Wilson, G. Apoptosis genes and resistance to cancer therapy: what do the experimental and clinical data tell us? Cancer Biol. Ther. 2, 477–490 (2003).
  Article CAS PubMed Google Scholar
• Altieri, D. C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol. Med. 7, 542–547 (2001).
  Article CAS PubMed Google Scholar
• Thames, H. D., Petersen, C., Petersen, S., Nieder, C. & Baumann, M. Immunohistochemically detected p53 mutations in epithelial tumors and results of treatment with chemotherapy and radiotherapy. A treatment-specific overview of the clinical data. Strahlenther. Onkol. 178, 411–421 (2002).
  Article PubMed Google Scholar
• Schmitt, C. A. & Lowe, S. W. Apoptosis and therapy. J. Pathol. 187, 127–137 (1999).
  Article CAS PubMed Google Scholar
• Kovacs, M. S., Yudoh, K., Evans, J. W., Menke, D. & Brown, J. M. Stable translocations detected by fluorescence in situ hybridization: a rapid surrogate end point to evaluate the efficacy of a potentiator of tumor response to radiotherapy. Cancer Res. 57, 672–677 (1997).
  CAS PubMed Google Scholar
• Castedo, M. et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825–2837 (2004).
  Article CAS PubMed Google Scholar